干扰素-γ介导的选择性造血抑制与再生障碍性贫血中缺乏HLA的造血干祖细胞的克隆优势
获得性再生障碍性贫血(AA)中约30%患者存在缺乏HLA I类等位基因的白细胞(HLA[-])。研究利用不同HLA基因型的诱导多能干细胞(iPSCs)来源的造血干祖细胞(HSPCs)发现,HLA(-) HSPCs对干扰素-γ(IFN-γ)的抑制作用抵抗,而表达HLA I类分子的HSPCs生长受抑。IFN-γ刺激下WT HSPCs的CD119表达增强并激活促凋亡信号,pSTAT3表达降低,而HLA(-) HSPCs中pSTAT3表达升高,提示IFN-γ选择性抑制HSPCs可能促进克隆性造血并导致HLA(-) HSPCs在AA患者中持续存在。
要点
- 约30%的AA患者存在缺乏HLA I类等位基因的白细胞(HLA[-])。
- HLA(-) HSPCs对IFN-γ的抑制效应抵抗,而表达HLA I类分子的HSPCs生长受抑。
- IFN-γ刺激下WT HSPCs的pSTAT3表达降低,HLA(-) HSPCs中pSTAT3表达升高。
核心结论
- IFN-γ对HSPCs的选择性造血抑制可能促进克隆性造血并导致HLA(-) HSPCs在AA患者中持续存在。
研究设计与样本
- 利用不同HLA基因型的诱导多能干细胞(iPSCs)来源的造血干祖细胞(HSPCs)进行体外研究。
主要发现
- HLA(-) HSPCs对IFN-γ的抑制作用抵抗,而表达HLA I类分子的HSPCs生长和发育被IFN-γ有效抑制。
- 与HLA(-) HSPCs相比,WT HSPCs在IFN-γ刺激下CD119表达增强,激活下游促凋亡信号通路。
- IFN-γ刺激降低WT HSPCs中pSTAT3表达,而HLA(-) HSPCs中pSTAT3表达升高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acquired aplastic anemia (AA) is an immune-mediated bone marrow failure caused by autoreactive cytotoxic T lymphocytes targeting hematopoietic stem progenitor cells (HSPCs). Approximately 30% of AA patients exhibit leukocytes lacking HLA class I alleles (HLA[-]). In addition to this direct immune assault, the pathogenesis of AA is thought to involve indirect suppression mediated by the proinflammatory cytokine interferon-gamma (IFN-γ). Using HSPCs derived from induced pluripotent stem cells (iPSCs) with different HLA genotypes, HLA(-) HSPCs were found to be resistant to the suppressive effects of IFN-γ, whereas IFN-γ effectively suppressed the growth and development of HSPCs expressing HLA class I molecules. Further analysis showed that, in contrast to HLA(-) HSPCs, WT HSPCs showed enhanced CD119 expression in response to IFN-γ, activating downstream signaling pathways that promote apoptosis, suggesting that transcription factors involved in the apoptotic pathway following IFN-γ stimulation are differentially expressed between WT and HLA(-) HSPCs. Notably, IFN-γ stimulation reduced the expression of pSTAT3, a key regulator of apoptosis, in WT HSPCs, whereas its expression was elevated in HLA(-) HSPCs. In conclusion, this study showed that the selective hematopoietic inhibition of HSPCs by IFN-γ likely facilitates clonal hematopoiesis and contributes to the persistence of HLA(-) HSPCs in patients with AA.
引用
- Takahashi R, Takahashi H, Seoka L, et al. Interferon-γ-mediated selective inhibition of hematopoiesis and the clonal advantage of HLA-lacking hematopoietic stem progenitor cells in aplastic anemia. Leukemia. 2025. PMID: 40217071. doi:10.1038/s41375-025-02595-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。